comarum palustre
Botanicalexperimental
Comarum palustre, known by the common name marsh cinquefoil, also purple marshlocks and swamp cinquefoil, is a waterside rhizomatous subshrub. It has a circumboreal distribution, occurring throughout cool temperate Asia, Europe, and North America, particularly in northern regions. It is most commonly found on lake shores, marshy riversides and stream margins, often partly submerged with foliage floating. It is a parent of some Fragaria–Comarum hybrids, ornamental plants produced by crossing with strawberries. — Wikipedia
Clinical trial activity
1 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
1
Earliest trial started Jun 29, 2018 (NCT03530930)
Timeline
No events for the selected filters.
Indications
Approved for
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaComarum palustre ↗
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03530930 | Phase 4 | Jun 29, 2018 | Federal State Budgetary Scientific Institution, Research Institute of Fundamental and Clinical Immunology |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Federal State Budgetary Scientific Institution, Research Institute of Fundamental and Clinical Immunology | Academic/Hospital | 1 | 1 | 1 | 2018 |
1 organizations
Page 1 / 1